CN109527545A - 一种l-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法 - Google Patents
一种l-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法 Download PDFInfo
- Publication number
- CN109527545A CN109527545A CN201811460307.4A CN201811460307A CN109527545A CN 109527545 A CN109527545 A CN 109527545A CN 201811460307 A CN201811460307 A CN 201811460307A CN 109527545 A CN109527545 A CN 109527545A
- Authority
- CN
- China
- Prior art keywords
- powder
- freeze
- ferment
- arabinose
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 121
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 title claims abstract description 34
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000009472 formulation Methods 0.000 title description 5
- 241000894006 Bacteria Species 0.000 claims abstract description 57
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004615 ingredient Substances 0.000 claims abstract description 19
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 15
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 15
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 15
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 15
- 235000021014 blueberries Nutrition 0.000 claims abstract description 15
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 15
- 235000016623 Fragaria vesca Nutrition 0.000 claims abstract description 14
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims abstract description 14
- 229920001202 Inulin Polymers 0.000 claims abstract description 14
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 14
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 14
- 238000004108 freeze drying Methods 0.000 claims abstract description 14
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 14
- 229940029339 inulin Drugs 0.000 claims abstract description 14
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 14
- 239000004375 Dextrin Substances 0.000 claims abstract description 13
- 229920001353 Dextrin Polymers 0.000 claims abstract description 13
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 13
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 13
- 235000019425 dextrin Nutrition 0.000 claims abstract description 13
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims abstract description 13
- 239000000832 lactitol Substances 0.000 claims abstract description 13
- 229960003451 lactitol Drugs 0.000 claims abstract description 13
- 235000010448 lactitol Nutrition 0.000 claims abstract description 13
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims abstract description 12
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 12
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 12
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 12
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 12
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 12
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 12
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 12
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 12
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 12
- 239000001259 polydextrose Substances 0.000 claims abstract description 12
- 229940035035 polydextrose Drugs 0.000 claims abstract description 12
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 10
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 9
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 9
- 238000004806 packaging method and process Methods 0.000 claims abstract description 7
- 238000012545 processing Methods 0.000 claims abstract description 7
- 240000009088 Fragaria x ananassa Species 0.000 claims abstract 5
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 235000008939 whole milk Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 238000004945 emulsification Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 235000013351 cheese Nutrition 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims 2
- 229940039696 lactobacillus Drugs 0.000 claims 2
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 5
- 235000013336 milk Nutrition 0.000 abstract description 3
- 239000008267 milk Substances 0.000 abstract description 3
- 210000004080 milk Anatomy 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 10
- 241000220223 Fragaria Species 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 230000001151 other effect Effects 0.000 description 9
- 241000193830 Bacillus <bacterium> Species 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000012856 packing Methods 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000077233 Vaccinium uliginosum Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种L‑阿拉伯糖、酵素及益生菌冻干粉的配方，包括L‑阿拉伯糖、酵素粉、草莓粉、蓝莓粉、奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌。一种L‑阿拉伯糖、酵素及益生菌冻干粉的制备方法，包括三个步骤，步骤A：菌粉处理、菌粉冻干粉碎；步骤B:菌粉冻干粉碎后和主料混合；步骤C：包装出厂。本发明采用L‑阿拉伯糖、酵素粉、草莓粉、蓝莓粉、奶粉、菊粉等作为主料，乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌等作为辅料，制得的成品食用方便，能给人们提供更多营养成分以及有益菌，更利于身体健康。
Description
技术领域
本发明涉及食品配方及其制作方法领域，特别是一种L-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法。
背景技术
目前，我国存在着大量被肠道疾病困扰的消费者和肥胖者，他们仍在使用不科学甚至会带来巨大伤害的方法或产品，副作用频发，短时间无效，长时间反弹。因此，我们想做一款真正健康、科学、有效的产品，让更多消费者回归健康体魄和理想体型。
L-阿拉伯糖是一种健康物质，能有效抑制双糖吸收及抑制身体脂肪堆积，是预防"三高一超"(高血压、高血糖、高血脂、糖尿病、肥胖)的新资源食品；益生菌能够有效促进肠道菌群平衡，提高人体免疫力；酵素能够将食物分解为小分子，大量的膳食纤维可以吸水膨胀软化宿便，同时吸附粘连在肠壁上的宿便，促进肠道蠕动，有效排出宿便。所以长期服用本品可以达到通便、减肥，改善易胖体质的效果。
目前市面上大多数此类产品成分单一，因此不能给服用者提供更多的营养成分和科学的组合配方。
发明内容
为了克服传统产品成分单一，不能满足人们对各种物质的需求，服用后不能起到有效改善体质、通便减肥功效的弊端，本发明采用L-阿拉伯糖、酵素粉等作为主料，并加入各种对人体有益的益生菌与多种益生元作为辅料，制得的成品粉剂方便人们服用的同时，还能给人们提供更多的营养成分以及有益菌，从而更利于人体身体健康的一种L-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法。
本发明解决其技术问题所采用的技术方案是：
一种L-阿拉伯糖、酵素及益生菌冻干粉的配方，其特征在于包括L-阿拉伯糖、全脂奶粉、酵素粉、草莓粉、蓝莓粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌。
所述每份L-阿拉伯糖、酵素及益生菌冻干粉的配方中，各种原料成分如下，L-阿拉伯糖4-6克、酵素粉1-2克、草莓粉0.1-0.4克、蓝莓粉0.1-0.4克、全脂奶粉1.4-1.8克、菊粉0.1-0.2克、低聚果糖0.1-0.2克、低聚木糖0.03-0.07克、乳糖醇0.3-0.8克、抗性糊精0.03-0.07克、聚葡萄糖0.03-0.07克、低聚异麦芽糖0.03-0.07克、低聚半乳糖0.03-0.07克、乳双歧杆菌15-30亿单位、干酪乳杆菌15-40亿单位、嗜酸乳杆菌8-15亿单位、植物乳杆菌20-40亿单位、鼠李糖乳杆菌8-15亿单位、青春双歧杆菌0.5-2亿单位、长双歧杆菌0.5-2亿单位。
一种L-阿拉伯糖、酵素及益生菌冻干粉的制备方法，其特征在于包括三个步骤，步骤A：菌粉处理、菌粉冻干粉碎；步骤B:菌粉冻干粉碎后和主料混合；步骤C：包装出厂。
所述步骤A，菌粉处理、菌粉冻干粉碎工序中共分为四个步骤，第一：菌粉的乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌称料；第二:菌粉灭菌培养、杀灭有害细菌：第三：灭菌后菌粉离心乳化；第四：乳化后菌粉冻干粉碎备用。
所述步骤B，菌粉冻干粉碎后和主料混合工序中，将主料L-阿拉伯糖、酵素粉、草莓粉、蓝莓粉、全脂奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖称重后，和粉碎后菌粉在电动混合机机内混合，保证混合充分均匀。
本发明有益效果是：本发明采用L-阿拉伯糖、酵素粉、草莓粉、蓝莓粉、全脂奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖作为主料，乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌作为辅料，经科学配比制得的成品食用方便，方便人们服用的同时，还能给人们提供更多的营养成分以及有益菌，从而更利于人体身体健康。基于上述，所以本发明具有好的应用前景。
附图说明
以下结合附图和实施例将本发明做进一步说明。
图1是本发明一种L-阿拉伯糖、酵素及益生菌冻干粉的制备方法流程框图。
具体实施方式
一种L-阿拉伯糖、酵素及益生菌冻干粉的配方，包括L-阿拉伯糖、酵素粉、草莓粉、蓝莓粉、全脂奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌。
实施例1，每份L-阿拉伯糖、酵素及益生菌冻干粉的配方中，各种原料成分如下，L-阿拉伯糖4.0克、酵素粉1.0克、草莓粉0.5克、蓝莓粉0.5克、全脂奶粉2.0克、菊粉0.1克、低聚果糖0.1克、低聚木糖0.05克、乳糖醇0.5克、抗性糊精0.05克、聚葡萄糖0.05克、低聚异麦芽糖0.05克、低聚半乳糖0.05克、乳双歧杆菌20亿单位、干酪乳杆菌30亿单位、嗜酸乳杆菌10亿单位、植物乳杆菌30亿单位、鼠李糖乳杆菌10亿单位、青春双歧杆菌1亿单位、长双歧杆菌1亿单位。
实施例2，每份L-阿拉伯糖、酵素及益生菌冻干粉的配方中，各种原料成分如下，L-阿拉伯糖5克、酵素粉1.7克、草莓粉0.15克、蓝莓粉0.15克、全脂奶粉1.7克、菊粉0.15克、低聚果糖0.1克、低聚木糖0.06克、乳糖醇0.7克、抗性糊精0.04克、聚葡萄糖0.06克、低聚异麦芽糖0.05克、低聚半乳糖0.07克、乳双歧杆菌18亿单位、干酪乳杆菌31亿单位、嗜酸乳杆菌10亿单位、植物乳杆菌28亿单位、鼠李糖乳杆菌10亿单位、青春双歧杆菌1.2亿单位、长双歧杆菌1.2亿单位。
图1中所示，一种L-阿拉伯糖、酵素及益生菌冻干粉的制备方法，包括三个步骤，步骤A：菌粉处理、菌粉冻干粉碎；步骤B:菌粉冻干粉碎后和主料混合：步骤C：包装出厂。
图1中所示，步骤A：菌粉处理、菌粉冻干粉碎工序中共分为四个流程，第一：菌粉的乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌称料；第二:菌粉灭菌培养、杀灭有害细菌：第三：灭菌后菌粉离心乳化；第四：乳化后菌粉冻干粉碎备用。在称料中，应该严格按照配方、按照物料的比例称取，称量好的物料放在灭菌罐旁等待进入灭菌培养工序，并保证灭菌罐以及生产车间不得有霉菌霉斑等；菌粉灭菌培养在灭菌罐内进行；在进行乳化后菌粉冻干粉碎备用工序时，应该按照冻干工艺执行，夏天天热注意冷却水温度适宜，并注意压力表数据，粉碎后菌粉入库备用，粉碎后菌粉在零下18摄氏度左右保存。
图1中所示，步骤B：菌粉冻干粉碎后和主料混合工序中，将主料L-阿拉伯糖、酵素粉、草莓粉、蓝莓粉、全脂奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖称重后，和粉碎后菌粉在电动混合机机内混合，保证混合充分均匀。混合前注意主料和粉碎后菌粉是否结块，如有结块应该先进行预处理保证主料和菌粉都处于粉状；混合采用三维电动混合机进行物料混合能达到更好的混合效果。
图1中所示，步骤C：包装出厂工序中，将步骤B混合后得到的复方蓝莓营养粉先采用自动粉末包装机用包装袋进行内包装，内包装袋使用前用紫外线照射，包装中涉及到的生产设备严格消毒；内包装后产品检验合格后用包装机进行外包装，然后外包装后产品放入阴凉、干燥、通风良好的库房内储存，温度在摄氏25度左右、湿度小于百分之五十五。
本发明中，L-阿拉伯糖有预防"三高一超"(高血压、高血糖、高血脂、糖尿病、肥胖)等的功效；酵素粉能对肠道起到调理与保养，达到清肠、护肤、延年益寿等的功效；草莓粉有抗癌、预防心血管病、护肤、预防老年痴呆等的功效。蓝莓粉具有防止脑神经老化、并具有保护视力、强心、抗癌、软化血管、增强人机体免疫等功效。全脂奶粉能有效为人体提供各种营养成分；菊粉有降低血糖、控制血脂等功效；低聚果糖能降低血清中胆固醇和甘油三酯的含量、对肠道有益菌有增殖作用；低聚木糖能有效降低人体肠道有毒发酵产物及有害细菌酶的产生，还具有保护肝脏、降低血清胆固醇、降低血压、增强机体免疫力抗癌等功效；乳糖醇有预防肥胖以及增加人体肠道双歧增殖因子等的功效；抗性糊精有降血糖、助消化等功效；聚葡萄糖能有效预防肥胖、并还有降血糖反应等功效。低聚异麦芽糖作为高血压、高血脂、高血糖、冠心病、便秘、龋齿等患者的食品添加剂，具有安全的效果，可最大限度地满足那些喜爱甜食又担心发胖的人群食用；低聚半乳糖是人体肠道中双歧杆菌、嗜酸乳酸杆菌等有益菌极好的营养源和有效的增殖因子，可以改善人体肠道的消化吸收；乳双歧杆菌具有维护肠道正常细菌菌群平衡，抑制病原菌的生长，防止便秘、下痢和胃肠障碍的功效；干酪乳杆菌可降低血浆胆固醇，增强宿主对微生物病原体的非特异性抵抗力，加快清除肠道内病原体，治疗肠道菌群紊乱和增强肠道透性，防止食物过敏和急性腹泻；嗜酸乳杆菌具有调整人体肠道菌群平衡，抑制肠道不良微生物的增殖等功效；植物乳杆菌对致病菌有抑制作用，具有降低血清胆固醇含量和预防心血管疾病、维持肠道内菌群平衡等功效；鼠李糖乳杆菌具有调节肠道菌群、预防和治疗腹泻、排除毒素、预防龋齿、提高机体免疫力及抗癌等功效；青春双歧杆菌具有防治慢性腹泻、便秘、抗衰老等功效；长双歧杆菌具有调节肠道健康等功效。以上各种原料经科学配比制得的成品食用方便，方便人们服用的同时，还能给人们提供更多的营养成分以及有益菌，从而更利于人体身体健康。基于上述，所以本发明具有好的应用前景。
以上显示和描述了本发明的主要特征及本发明的优点，对于本领域技术人员而言，显然本发明限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (5)
1.一种L-阿拉伯糖、酵素及益生菌冻干粉的配方，其特征在于包括L-阿拉伯糖、酵素粉、草莓粉、蓝莓粉、全脂奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌。
2.根据权利要求1所述的一种L-阿拉伯糖、酵素及益生菌冻干粉的配方，其特征在于每份L-阿拉伯糖、酵素及益生菌冻干粉的配方中，各种原料成分如下，L-阿拉伯糖4-6克、酵素粉1-2克、草莓粉0.1-0.4克、蓝莓粉0.1-0.4克、全脂奶粉1.4-1.8克、菊粉0.1-0.2克、低聚果糖0.1-0.2克、低聚木糖0.03-0.07克、乳糖醇0.3-0.8克、抗性糊精0.03-0.07克、聚葡萄糖0.03-0.07克、低聚异麦芽糖0.03-0.07克、低聚半乳糖0.03-0.07克、乳双歧杆菌15-30亿单位、干酪乳杆菌15-40亿单位、嗜酸乳杆菌8-15亿单位、植物乳杆菌20-40亿单位、鼠李糖乳杆菌8-15亿单位、青春双歧杆菌0.5-2亿单位、长双歧杆菌0.5-2亿单位。
3.根据权利要求1所述的一种L-阿拉伯糖、酵素及益生菌冻干粉的制备方法，其特征在于包括三个步骤，步骤A：菌粉处理、菌粉冻干粉碎；步骤B:菌粉冻干粉碎后和主料混合；步骤C：包装出厂。
4.根据权利要求3所述的一种L-阿拉伯糖、酵素及益生菌冻干粉的制备方法，其特征在于步骤A，菌粉处理、菌粉冻干粉碎工序中共分为四个步骤，第一：菌粉的乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、青春双歧杆菌、长双歧杆菌称料；第二:菌粉灭菌培养、杀灭有害细菌：第三：灭菌后菌粉离心乳化；第四：乳化后菌粉冻干粉碎备用。
5.根据权利要求4所述的一种L-阿拉伯糖、酵素及益生菌冻干粉的制备方法，其特征在于步骤B，菌粉冻干粉碎后和主料混合工序中，将主料L-阿拉伯糖、酵素粉、草莓粉、蓝莓粉、全脂奶粉、菊粉、低聚果糖、低聚木糖、乳糖醇、抗性糊精、聚葡萄糖、低聚异麦芽糖、低聚半乳糖称重后，和粉碎后菌粉在电动混合机机内混合，保证混合充分均匀。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811460307.4A CN109527545A (zh) | 2018-12-01 | 2018-12-01 | 一种l-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811460307.4A CN109527545A (zh) | 2018-12-01 | 2018-12-01 | 一种l-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109527545A true CN109527545A (zh) | 2019-03-29 |
Family
ID=65851755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811460307.4A Pending CN109527545A (zh) | 2018-12-01 | 2018-12-01 | 一种l-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109527545A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111035660A (zh) * | 2020-01-13 | 2020-04-21 | 刘敏 | 吸收效果好的多边胃粘膜益生菌粉剂 |
| CN111772175A (zh) * | 2019-09-10 | 2020-10-16 | 浙江康叶源健康科技有限公司 | 一种酵素和益生菌以及酵母-β葡聚糖三合一的营养食品 |
| CN114521590A (zh) * | 2022-03-18 | 2022-05-24 | 珠海中食果肽健康科技有限公司 | 阻断糖、油脂吸收的白芸豆益生菌减脂片及其制备方法 |
| CN116726054A (zh) * | 2022-12-05 | 2023-09-12 | 山东新时代药业有限公司 | 一种即食型益生菌组合物及其制备方法、用途 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105661245A (zh) * | 2016-01-29 | 2016-06-15 | 江苏微康生物科技有限公司 | 一种益生菌型果蔬酵素固体饮料 |
| CN106173773A (zh) * | 2016-07-06 | 2016-12-07 | 慧谷生命科技湖北有限公司 | 一种酵素益生菌固体饮料及其制备方法 |
| TWM536946U (zh) * | 2016-05-12 | 2017-02-21 | Evergreen Bio-Medical Technology Co Ltd | 含有阿拉伯糖之益生菌的食品結構 |
| CN106579387A (zh) * | 2016-12-16 | 2017-04-26 | 南京糖防生物科技有限公司 | 一种阿拉伯糖酵素组合物及制备方法 |
-
2018
- 2018-12-01 CN CN201811460307.4A patent/CN109527545A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105661245A (zh) * | 2016-01-29 | 2016-06-15 | 江苏微康生物科技有限公司 | 一种益生菌型果蔬酵素固体饮料 |
| TWM536946U (zh) * | 2016-05-12 | 2017-02-21 | Evergreen Bio-Medical Technology Co Ltd | 含有阿拉伯糖之益生菌的食品結構 |
| CN106173773A (zh) * | 2016-07-06 | 2016-12-07 | 慧谷生命科技湖北有限公司 | 一种酵素益生菌固体饮料及其制备方法 |
| CN106579387A (zh) * | 2016-12-16 | 2017-04-26 | 南京糖防生物科技有限公司 | 一种阿拉伯糖酵素组合物及制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 佚名: "济南先大酵18——徐桂亮品牌设计", 《HTTP://WWW.CNDESIGN.COM/OPUS/5C8284AD-8127-4BEE-81D6-A996012A938D.HTML》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111772175A (zh) * | 2019-09-10 | 2020-10-16 | 浙江康叶源健康科技有限公司 | 一种酵素和益生菌以及酵母-β葡聚糖三合一的营养食品 |
| CN111035660A (zh) * | 2020-01-13 | 2020-04-21 | 刘敏 | 吸收效果好的多边胃粘膜益生菌粉剂 |
| CN114521590A (zh) * | 2022-03-18 | 2022-05-24 | 珠海中食果肽健康科技有限公司 | 阻断糖、油脂吸收的白芸豆益生菌减脂片及其制备方法 |
| CN116726054A (zh) * | 2022-12-05 | 2023-09-12 | 山东新时代药业有限公司 | 一种即食型益生菌组合物及其制备方法、用途 |
| CN116726054B (zh) * | 2022-12-05 | 2024-03-26 | 山东新时代药业有限公司 | 一种即食型益生菌组合物及其制备方法、用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107115364B (zh) | 一种复合益生菌及其制备方法 | |
| CN109527545A (zh) | 一种l-阿拉伯糖、酵素及益生菌冻干粉的配方及制备方法 | |
| JP2020120657A (ja) | 非配糖体が細胞内に蓄積されている微生物製剤の製造方法およびこれにより製造された微生物製剤 | |
| RU2518293C2 (ru) | Средство против ожирения, питание или напиток против ожирения, улучшающее толерантность к глюкозе средство и питание или напиток для улучшения толерантности к глюкозе | |
| US12022844B2 (en) | Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition | |
| CN105454966A (zh) | 改善胃肠道且提高免疫力的益生菌固体饮料及其制备方法 | |
| CN108142770A (zh) | 一种乳肽多元益生菌固体饮料 | |
| EP2101593A1 (en) | A probiotic oat-based food product and process for making the same | |
| Kumari et al. | Probiotics, prebiotics, and synbiotics: Current status and future uses for human health | |
| CN107095292A (zh) | 一种具有调节肠道菌群功能的植物复合酵素及其制备方法 | |
| CN109287920A (zh) | 一种多元维生素与多联益生菌的固体饮料及其制作方法 | |
| CN103798391A (zh) | 一种治疗婴童乳糖不耐症、腹泻的食品及其制备方法 | |
| EP3202892A1 (en) | Uses of bacteroides in treatment or prevention of obesity-related diseases | |
| CN111000246A (zh) | 一种辅助降甘油三酯的益生菌膳食纤维组合物及其应用、保健品 | |
| US20100028489A1 (en) | Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization | |
| CN104855510A (zh) | 一种青稞红曲酸奶及其制备方法 | |
| EP3202891B1 (en) | Uses of bacteroides in treatment or prevention of obesity or diabetes | |
| TW202207957A (zh) | 具有優異的耐酸性和耐膽汁性且對血脂異常症具有預防或治療效果的新型短雙歧桿菌idcc 4401菌株及其死菌體id-bbr4401 | |
| CN105266162B (zh) | 一种兼具整肠及调节免疫力的纳豆软胶囊保健食品 | |
| CN107950864A (zh) | 一种合生元谷蔬代餐粉及其制备方法和应用 | |
| CN107660670A (zh) | 苦荞益生菌饮品及其制备方法 | |
| CN103918795A (zh) | 一种茶多酚益生菌羊奶片及其制备方法 | |
| CN102742654B (zh) | 一种养颜美容益生菌羊奶片及其制备方法 | |
| RU2332113C1 (ru) | Биоовсяный питьевой пищевой продукт | |
| Iorgachev et al. | Synbiotic additives in the waffles technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |